Johan Spoor
Director Ejecutivo en PERSPECTIVE THERAPEUTICS, INC. .
Fortuna: 286 449 $ al 31/05/2024
Perfil
Johan M.
Spoor was the founder of Entero Therapeutics, Inc. (founded in 2014) and held the title of Director.
He is currently the President, Chief Executive Officer & Director at FluoroPharma, Inc. (since 2010), the Chief Executive Officer & Director at Perspective Therapeutics, Inc. (since 2023), an Independent Director at AtheroNova, Inc. (since 2012), and a Director at AeacusBio and Verifi Water, Inc. Mr. Spoor has previously held positions as the Chief Executive Officer & Director at IsoRay, Inc., the Chief Executive Officer at Viewpoint Molecular Targeting, Inc. (2022-2023), the President & Chief Executive Officer at KBP Biosciences USA, Inc. (2019-2021), a Director at Photovoltaic Solar Cells, Inc. (2012), a Director at FluoroPharma Medical, Inc. (2010-2015), an Independent Director at Protea Biosciences Group, Inc. (2013-2014), an Independent Director at MetaStat, Inc. (2012-2016), a Research Analyst at Credit Suisse Securities (USA) LLC (Broker) (2005-2007), a Research Analyst at JPMorgan Securities LLC (2007-2008), and the Chief Financial Officer at Sunstone Biosciences, Inc. Mr. Spoor has an undergraduate degree from the University of Toronto (1994) and an MBA from Columbia Business School.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 13/06/2024 | 207 572 ( 0.03% ) | 286 449 $ | 31/05/2024 |
Cargos activos de Johan Spoor
| Empresas | Cargo | Inicio |
|---|---|---|
| ATHERONOVA INC. | Director/Miembro de la Junta | 03/01/2012 |
| PERSPECTIVE THERAPEUTICS, INC. | Director Ejecutivo | 03/02/2023 |
AeacusBio
 AeacusBio Industrial MachineryProducer Manufacturing AeacusBio manufactures water monitoring surveillance systems for monitoring water quality and purity. The private company is based in Montclair, NJ. | Director/Miembro de la Junta | - |
FluoroPharma, Inc.
 FluoroPharma, Inc. Medical SpecialtiesHealth Technology FluoroPharma, Inc. manufactures diagnostic imaging products. It engages in the discovery, development and commercialization of proprietary diagnostic imaging products. The company was founded by David R. Elmaleh in 2003 and is headquartered in Boston, MA. | Director Ejecutivo | 17/09/2010 |
Antiguos cargos conocidos de Johan Spoor.
| Empresas | Cargo | Fin |
|---|---|---|
Viewpoint Molecular Targeting, Inc.
 Viewpoint Molecular Targeting, Inc. Miscellaneous Commercial ServicesCommercial Services Viewpoint Molecular Targeting, Inc. develops pharmaceutical drugs for diagnostic imaging and therapy for cancer. The firm?s radiopharmaceutical drugs are designed to specifically localize in cancerous tissues in the human body. The company was founded by Frances L. Johnson, Michael K. Schultz and Heyward H. Coleman in 2008 and is headquartered in Coralville, IA. | Director Ejecutivo | 03/02/2023 |
KBP Biosciences USA, Inc.
 KBP Biosciences USA, Inc. Miscellaneous Commercial ServicesCommercial Services KBP Biosciences engages in conducting biotechnological research to develop therapies for patients. The company was founded by Huang Zhenhua in and is headquartered in Princeton, NJ. | Director Ejecutivo | 01/06/2021 |
| ENTERO THERAPEUTICS, INC. | Director Ejecutivo | 08/10/2019 |
| METASTAT, INC. | Presidente | 15/10/2014 |
| FLUOROPHARMA MEDICAL, INC. | Director Ejecutivo | 28/12/2015 |
Formación de Johan Spoor.
| University of Toronto | Undergraduate Degree |
| Columbia Business School | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 4 |
|---|---|
| METASTAT, INC. | Producer Manufacturing |
| FLUOROPHARMA MEDICAL, INC. | Commercial Services |
| ENTERO THERAPEUTICS, INC. | Health Technology |
| PERSPECTIVE THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 11 |
|---|---|
Credit Suisse Securities (USA) LLC (Broker)
 Credit Suisse Securities (USA) LLC (Broker) Investment Banks/BrokersFinance Credit Suisse Securities (USA) LLC (Credit Suisse Securities USA) is the broker/dealer division of Credit Suisse Securities (USA) LLC, an investment banking company headquartered in New York City. The firm was founded in 1998 and is a wholly owned subsidiary of Credit Suisse (USA), Inc., ultimately owned by Credit Suisse Group AG (SWX: CSGN) in Switzerland. Credit Suisse Securities USA offers a suite of equities, solutions and credit products and services which includes global securities sales, trading and execution, prime brokerage and comprehensive investment research. Their clients include financial institutions, corporations, governments, institutional investors, such as pension funds and hedge funds, and private individuals around the world. | Finance |
FluoroPharma, Inc.
FluoroPharma, Inc. Medical SpecialtiesHealth Technology FluoroPharma, Inc. manufactures diagnostic imaging products. It engages in the discovery, development and commercialization of proprietary diagnostic imaging products. The company was founded by David R. Elmaleh in 2003 and is headquartered in Boston, MA. | Health Technology |
| Sunstone Biosciences, Inc. | |
AtheroNova, Inc.
 AtheroNova, Inc. Pharmaceuticals: MajorHealth Technology AtheroNova, Inc. operates as biotechnology company. The company engages in the research and development, marketing, and sale of pharmaceutical preparations and pharmaceutical intellectual property. It develops intellectual property that uses certain pharmacological compounds for the treatment of atherosclerosis, which is the primary cause of various cardiovascular diseases. The company was founded by Giorgio Zadini and Filiberto Zadini in 1997 and is headquartered in Irvine, CA. | Health Technology |
Photovoltaic Solar Cells, Inc.
 Photovoltaic Solar Cells, Inc. Financial ConglomeratesFinance Photovoltaic Solar Cells, Inc. is a development stage company. It engages in identifying, investigating and if warranted, acquiring companies. The company was founded by Lawrence F. Curtin on March 28, 2007 and is headquartered in New York, NY. | Finance |
JPMorgan Securities LLC
 JPMorgan Securities LLC Investment ManagersFinance JPMorgan Securities LLC (JPMS) is a securities brokerage firm headquartered in New York City. The firm was founded in 1985 and is a subsidiary of JPMorgan Broker-Dealer Holdings, Inc., ultimately held by JPMorgan Chase & Co., Inc. (NYSE: JPM). JPMS provides research on fixed income, credit, derivatives, emerging markets, foreign exchange, structured finance, technical analysis and bond indices. Their equity analysts cover equities throughout North America, EMEA, Asia/Pacific and the emerging markets. The firm's fixed income team formulates trading and portfolio recommendations for investors in global bonds and other fixed-income markets based on valuations, analytics and market dynamics. | Finance |
Protea Biosciences Group, Inc.
 Protea Biosciences Group, Inc. Miscellaneous Commercial ServicesCommercial Services Protea Biosciences Group, Inc. engaged in the provision of molecular information services. It offers direct analysis, mapping, and display of biologically active molecules in living cells and tissue samples through its platform technology. The company was founded by Stephen C. Turner in July 2001 and was headquartered in Morgantown, WV. | Commercial Services |
AeacusBio
AeacusBio Industrial MachineryProducer Manufacturing AeacusBio manufactures water monitoring surveillance systems for monitoring water quality and purity. The private company is based in Montclair, NJ. | Producer Manufacturing |
KBP Biosciences USA, Inc.
KBP Biosciences USA, Inc. Miscellaneous Commercial ServicesCommercial Services KBP Biosciences engages in conducting biotechnological research to develop therapies for patients. The company was founded by Huang Zhenhua in and is headquartered in Princeton, NJ. | Commercial Services |
Viewpoint Molecular Targeting, Inc.
Viewpoint Molecular Targeting, Inc. Miscellaneous Commercial ServicesCommercial Services Viewpoint Molecular Targeting, Inc. develops pharmaceutical drugs for diagnostic imaging and therapy for cancer. The firm?s radiopharmaceutical drugs are designed to specifically localize in cancerous tissues in the human body. The company was founded by Frances L. Johnson, Michael K. Schultz and Heyward H. Coleman in 2008 and is headquartered in Coralville, IA. | Commercial Services |
IsoRay, Inc.
 IsoRay, Inc. Medical SpecialtiesHealth Technology IsoRay, Inc. is a medical technology company, which engages in the development, manufacture, and sale of isotope-based medical products and devices. The firm focuses on the treatment of cancer and other malignant diseases. Its core product is Cesium-131, a radioisotope for the treatment of malignant tumors. The company was founded by Lance A. Bray in 1983 and is headquartered in Richland, WA. | Health Technology |
- Bolsa de valores
- Insiders
- Johan Spoor
